Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Handler

Showing results (81-90 of 122) with videos related to

Pageof 13
Sort By:
Toxicology and Applied Pharmacology|March 1, 1993
Temporal relationship of changes in hepatobiliary function and morphology in rats following alpha-naphthylisothiocyanate (ANIT) administrationD C Kossor, P C Meunier, J A Handler, et al.
Annals of Clinical and Laboratory Science|July 1, 1988
Involvement of hormones in the swift increase in alcohol metabolismD T Forman, B U Bradford, J A Handler, et al.
AIDS Education and Prevention : Official Publication of the International Society for AIDS Education|February 1, 1997
Does parental involvement make a difference? The impact of parent interactive activities on students in a school-based AIDS prevention programK Weeks, S R Levy, A K Gordon, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 5, 2012
MLR-1023 is a potent and selective allosteric activator of Lyn kinase in vitro that improves glucose tolerance in vivoMichael S Saporito, Alexander R Ochman, Christopher A Lipinski, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 21, 2012
The Lyn kinase activator MLR-1023 is a novel insulin receptor potentiator that elicits a rapid-onset and durable improvement in glucose homeostasis in animal models of type 2 diabetesAlexander R Ochman, Christopher A Lipinski, Jeffrey A Handler, et al.
The Biochemical Journal|December 1, 1987
Inhibition of catalase-dependent ethanol metabolism in alcohol dehydrogenase-deficient deermice by fructoseJ A Handler, B U Bradford, E B Glassman, et al.
International Journal of Dermatology|March 22, 2017
Porphyria cutanea tarda: an intriguing genetic disease and markerNancy S Handler, Marc Z Handler, Matthew P Stephany, et al.
International Journal of STD & AIDS|July 19, 2012
Gender inequities in sexual risks among youth with HIV in Kigali, RwandaF S Test, S D Mehta, A Handler, et al.
The Journal of Biological Chemistry|July 5, 1991
Studies on the reduction of endogenously generated prostaglandin G2 by prostaglandin H synthaseT E Eling, W C Glasgow, J F Curtis, et al.
Frontiers in Digital Health|October 6, 2025
Increasing access to care through digital health for the Medicaid population: a novel community case studyMelinda Cooling, Colleen J Klein, Matthew D Dalstrom, et al.
Pageof 13

Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
Toxicology and Applied Pharmacology|March 1, 1993
Temporal relationship of changes in hepatobiliary function and morphology in rats following alpha-naphthylisothiocyanate (ANIT) administrationD C Kossor, P C Meunier, J A Handler, et al.
Annals of Clinical and Laboratory Science|July 1, 1988
Involvement of hormones in the swift increase in alcohol metabolismD T Forman, B U Bradford, J A Handler, et al.
AIDS Education and Prevention : Official Publication of the International Society for AIDS Education|February 1, 1997
Does parental involvement make a difference? The impact of parent interactive activities on students in a school-based AIDS prevention programK Weeks, S R Levy, A K Gordon, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 5, 2012
MLR-1023 is a potent and selective allosteric activator of Lyn kinase in vitro that improves glucose tolerance in vivoMichael S Saporito, Alexander R Ochman, Christopher A Lipinski, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 21, 2012
The Lyn kinase activator MLR-1023 is a novel insulin receptor potentiator that elicits a rapid-onset and durable improvement in glucose homeostasis in animal models of type 2 diabetesAlexander R Ochman, Christopher A Lipinski, Jeffrey A Handler, et al.
The Biochemical Journal|December 1, 1987
Inhibition of catalase-dependent ethanol metabolism in alcohol dehydrogenase-deficient deermice by fructoseJ A Handler, B U Bradford, E B Glassman, et al.
International Journal of Dermatology|March 22, 2017
Porphyria cutanea tarda: an intriguing genetic disease and markerNancy S Handler, Marc Z Handler, Matthew P Stephany, et al.
International Journal of STD & AIDS|July 19, 2012
Gender inequities in sexual risks among youth with HIV in Kigali, RwandaF S Test, S D Mehta, A Handler, et al.
The Journal of Biological Chemistry|July 5, 1991
Studies on the reduction of endogenously generated prostaglandin G2 by prostaglandin H synthaseT E Eling, W C Glasgow, J F Curtis, et al.
Frontiers in Digital Health|October 6, 2025
Increasing access to care through digital health for the Medicaid population: a novel community case studyMelinda Cooling, Colleen J Klein, Matthew D Dalstrom, et al.
Pageof 13